Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Asymmetric TDP-43 distribution in primary progressive aphasia with progranulin mutation.

Gliebus G, Bigio EH, Gasho K, Mishra M, Caplan D, Mesulam MM, Geula C.

Neurology. 2010 May 18;74(20):1607-10. doi: 10.1212/WNL.0b013e3181df0a1b.

2.

Asymmetric pathology in primary progressive aphasia with progranulin mutations and TDP inclusions.

Kim G, Ahmadian SS, Peterson M, Parton Z, Memon R, Weintraub S, Rademaker A, Bigio E, Mesulam MM, Geula C.

Neurology. 2016 Feb 16;86(7):627-36. doi: 10.1212/WNL.0000000000002375. Epub 2016 Jan 20.

3.

Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia.

Gefen T, Gasho K, Rademaker A, Lalehzari M, Weintraub S, Rogalski E, Wieneke C, Bigio E, Geula C, Mesulam MM.

Brain. 2012 May;135(Pt 5):1554-65. doi: 10.1093/brain/aws076. Epub 2012 Apr 19.

5.

Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.

Kadokura A, Yamazaki T, Lemere CA, Takatama M, Okamoto K.

Neuropathology. 2009 Oct;29(5):566-73. doi: 10.1111/j.1440-1789.2009.01017.x. Epub 2009 Apr 21.

PMID:
19422539
6.

Fine structural analysis of the neuronal inclusions of frontotemporal lobar degeneration with TDP-43 proteinopathy.

Thorpe JR, Tang H, Atherton J, Cairns NJ.

J Neural Transm (Vienna). 2008 Dec;115(12):1661-71. doi: 10.1007/s00702-008-0137-1. Epub 2008 Oct 31.

7.

Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia.

Mesulam M, Wicklund A, Johnson N, Rogalski E, Léger GC, Rademaker A, Weintraub S, Bigio EH.

Ann Neurol. 2008 Jun;63(6):709-19. doi: 10.1002/ana.21388.

8.

A quantitative study of the neuropathology of 32 sporadic and familial cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).

Armstrong RA, Carter D, Cairns NJ.

Neuropathol Appl Neurobiol. 2012 Feb;38(1):25-38. doi: 10.1111/j.1365-2990.2011.01188.x.

9.

Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.

Bieniek KF, Murray ME, Rutherford NJ, Castanedes-Casey M, DeJesus-Hernandez M, Liesinger AM, Baker MC, Boylan KB, Rademakers R, Dickson DW.

Acta Neuropathol. 2013 Feb;125(2):289-302. doi: 10.1007/s00401-012-1048-7. Epub 2012 Sep 28.

10.

TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease.

Bigio EH, Mishra M, Hatanpaa KJ, White CL 3rd, Johnson N, Rademaker A, Weitner BB, Deng HX, Dubner SD, Weintraub S, Mesulam M.

Acta Neuropathol. 2010 Jul;120(1):43-54. doi: 10.1007/s00401-010-0681-2. Epub 2010 Apr 2.

11.

Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative.

Rademakers R, Baker M, Gass J, Adamson J, Huey ED, Momeni P, Spina S, Coppola G, Karydas AM, Stewart H, Johnson N, Hsiung GY, Kelley B, Kuntz K, Steinbart E, Wood EM, Yu CE, Josephs K, Sorenson E, Womack KB, Weintraub S, Pickering-Brown SM, Schofield PR, Brooks WS, Van Deerlin VM, Snowden J, Clark CM, Kertesz A, Boylan K, Ghetti B, Neary D, Schellenberg GD, Beach TG, Mesulam M, Mann D, Grafman J, Mackenzie IR, Feldman H, Bird T, Petersen R, Knopman D, Boeve B, Geschwind DH, Miller B, Wszolek Z, Lippa C, Bigio EH, Dickson D, Graff-Radford N, Hutton M.

Lancet Neurol. 2007 Oct;6(10):857-68. Erratum in: Lancet Neurol. 2007 Dec;6(12):1037.

PMID:
17826340
12.

Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies.

Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, Grossman M, Miller BL, Kretzschmar HA, Lee VM, Trojanowski JQ, Neumann M.

J Neuropathol Exp Neurol. 2008 Jun;67(6):555-64. doi: 10.1097/NEN.0b013e31817713b5.

13.

Cortical degeneration in frontotemporal lobar degeneration with TDP-43 proteinopathy caused by progranulin gene mutation.

Armstrong RA.

Int J Neurosci. 2014 Dec;124(12):894-903. doi: 10.3109/00207454.2014.890620. Epub 2014 Mar 3.

PMID:
24494724
14.

Prediction of pathology in primary progressive language and speech disorders.

Deramecourt V, Lebert F, Debachy B, Mackowiak-Cordoliani MA, Bombois S, Kerdraon O, Buée L, Maurage CA, Pasquier F.

Neurology. 2010 Jan 5;74(1):42-9. doi: 10.1212/WNL.0b013e3181c7198e. Epub 2009 Nov 25.

PMID:
19940270
15.

Progressive nonfluent aphasia: a rare clinical subtype of FTLD-TDP in Japan.

Aoki N, Tsuchiya K, Kobayashi Z, Arai T, Togo T, Miyazaki H, Kondo H, Ishizu H, Uchikado H, Katsuse O, Hirayasu Y, Akiyama H.

Neuropathology. 2012 Jun;32(3):272-9. doi: 10.1111/j.1440-1789.2011.01253.x. Epub 2011 Oct 6.

PMID:
21978320
16.

Brain progranulin expression in GRN-associated frontotemporal lobar degeneration.

Chen-Plotkin AS, Xiao J, Geser F, Martinez-Lage M, Grossman M, Unger T, Wood EM, Van Deerlin VM, Trojanowski JQ, Lee VM.

Acta Neuropathol. 2010 Jan;119(1):111-22. doi: 10.1007/s00401-009-0576-2. Epub 2009 Aug 2.

17.

A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series.

Beck J, Rohrer JD, Campbell T, Isaacs A, Morrison KE, Goodall EF, Warrington EK, Stevens J, Revesz T, Holton J, Al-Sarraj S, King A, Scahill R, Warren JD, Fox NC, Rossor MN, Collinge J, Mead S.

Brain. 2008 Mar;131(Pt 3):706-20. doi: 10.1093/brain/awm320. Epub 2008 Jan 29.

18.
19.

Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia.

Mesulam MM, Weintraub S, Rogalski EJ, Wieneke C, Geula C, Bigio EH.

Brain. 2014 Apr;137(Pt 4):1176-92. doi: 10.1093/brain/awu024. Epub 2014 Feb 25.

20.

Clinicopathologic correlation in PGRN mutations.

Davion S, Johnson N, Weintraub S, Mesulam MM, Engberg A, Mishra M, Baker M, Adamson J, Hutton M, Rademakers R, Bigio EH.

Neurology. 2007 Sep 11;69(11):1113-21. Epub 2007 May 23.

Supplemental Content

Support Center